Patent ID: 11945790
Assignee: IMMUNOMOLECULAR THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 2:
3. The pharmaceutical composition of claim 1, wherein Ar is, , where Ra, Rb, Rc, Rd and Re are each independently H, optionally substituted C1-C6-alkyl, halo, R6O—, R6S—, R6C(O)—, R7OC(O)—, optionally substituted C3-C8-cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl or optionally substituted heteroaryl; alternatively, Ra and Rb or Rb and Rc, together with the carbon atoms to which they are attached, form an optionally substituted carbocyclic or heterocyclic; R6 is optionally substituted C1-C6-alkyl, optionally substituted C3-C8-cycloalkyl, optionally substituted 3- to 8-membered heterocycloalkyl, optionally substituted aryl or optionally substituted heteroaryl; and R7 is H or optionally substituted C1-C6-alkyl.